Option implied volatility on companies working on combating Zika Inovio (NASDAQ:INO) 30-day implied volatility is at 64, compared to its 52-week range of 49 to 115. Cerus (CERS) 30-day implied volatility is at 54, compared to its 52-week range of 42 to 89. Intrexon (XON) 30-day implied volatility is at 71, compared to its 52-week range of 63 to 108. Implied volatility is the volatility expectation that is priced into individual options. All the inputs of an options pricing model are known (time to expiration, strike, price, interest rates) except for the volatility that the option is pricing in.
About 1.04M shares traded hands. Inovio Pharmaceuticals Inc (NASDAQ:INO) has risen 54.50% since February 8, 2016 and is uptrending. It has outperformed by 38.01% the S&P500.
Inovio Pharmaceuticals, Inc. is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The company has a market cap of $742.61 million. The Company’s DNA immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It currently has negative earnings. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.